{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:52:06Z","timestamp":1783734726098,"version":"3.55.0"},"reference-count":183,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:00:00Z","timestamp":1707004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FAR\u2014Fondo di Ateneo per la Ricerca 2019","award":["166835"],"award-info":[{"award-number":["166835"]}]},{"name":"FAR\u2014Fondo di Ateneo per la Ricerca 2019","award":["E95F21002320001"],"award-info":[{"award-number":["E95F21002320001"]}]},{"name":"FAR\u2014Fondo di Ateneo per la Ricerca 2019","award":["17-I-13884-1"],"award-info":[{"award-number":["17-I-13884-1"]}]},{"name":"FAR\u2014Fondo di Ateneo per la Ricerca 2019","award":["ANR-22-CE92-0076"],"award-info":[{"award-number":["ANR-22-CE92-0076"]}]},{"name":"FAR\u2014Fondo di Ateneo per la Ricerca 2019","award":["860070"],"award-info":[{"award-number":["860070"]}]},{"name":"Banca Popolare dell\u2019Emilia-Romagna (BPER)","award":["166835"],"award-info":[{"award-number":["166835"]}]},{"name":"Banca Popolare dell\u2019Emilia-Romagna (BPER)","award":["E95F21002320001"],"award-info":[{"award-number":["E95F21002320001"]}]},{"name":"Banca Popolare dell\u2019Emilia-Romagna (BPER)","award":["17-I-13884-1"],"award-info":[{"award-number":["17-I-13884-1"]}]},{"name":"Banca Popolare dell\u2019Emilia-Romagna (BPER)","award":["ANR-22-CE92-0076"],"award-info":[{"award-number":["ANR-22-CE92-0076"]}]},{"name":"Banca Popolare dell\u2019Emilia-Romagna (BPER)","award":["860070"],"award-info":[{"award-number":["860070"]}]},{"name":"Italian funding program Fondo Sociale Europeo REACT-EU\u2014PON","award":["166835"],"award-info":[{"award-number":["166835"]}]},{"name":"Italian funding program Fondo Sociale Europeo REACT-EU\u2014PON","award":["E95F21002320001"],"award-info":[{"award-number":["E95F21002320001"]}]},{"name":"Italian funding program Fondo Sociale Europeo REACT-EU\u2014PON","award":["17-I-13884-1"],"award-info":[{"award-number":["17-I-13884-1"]}]},{"name":"Italian funding program Fondo Sociale Europeo REACT-EU\u2014PON","award":["ANR-22-CE92-0076"],"award-info":[{"award-number":["ANR-22-CE92-0076"]}]},{"name":"Italian funding program Fondo Sociale Europeo REACT-EU\u2014PON","award":["860070"],"award-info":[{"award-number":["860070"]}]},{"DOI":"10.13039\/501100001665","name":"PRCI DFG-ANR funding program","doi-asserted-by":"publisher","award":["166835"],"award-info":[{"award-number":["166835"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"PRCI DFG-ANR funding program","doi-asserted-by":"publisher","award":["E95F21002320001"],"award-info":[{"award-number":["E95F21002320001"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"PRCI DFG-ANR funding program","doi-asserted-by":"publisher","award":["17-I-13884-1"],"award-info":[{"award-number":["17-I-13884-1"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"PRCI DFG-ANR funding program","doi-asserted-by":"publisher","award":["ANR-22-CE92-0076"],"award-info":[{"award-number":["ANR-22-CE92-0076"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"PRCI DFG-ANR funding program","doi-asserted-by":"publisher","award":["860070"],"award-info":[{"award-number":["860070"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"TubInTrain project","doi-asserted-by":"publisher","award":["166835"],"award-info":[{"award-number":["166835"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"TubInTrain project","doi-asserted-by":"publisher","award":["E95F21002320001"],"award-info":[{"award-number":["E95F21002320001"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"TubInTrain project","doi-asserted-by":"publisher","award":["17-I-13884-1"],"award-info":[{"award-number":["17-I-13884-1"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"TubInTrain project","doi-asserted-by":"publisher","award":["ANR-22-CE92-0076"],"award-info":[{"award-number":["ANR-22-CE92-0076"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"TubInTrain project","doi-asserted-by":"publisher","award":["860070"],"award-info":[{"award-number":["860070"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MDPI","award":["166835"],"award-info":[{"award-number":["166835"]}]},{"name":"MDPI","award":["E95F21002320001"],"award-info":[{"award-number":["E95F21002320001"]}]},{"name":"MDPI","award":["17-I-13884-1"],"award-info":[{"award-number":["17-I-13884-1"]}]},{"name":"MDPI","award":["ANR-22-CE92-0076"],"award-info":[{"award-number":["ANR-22-CE92-0076"]}]},{"name":"MDPI","award":["860070"],"award-info":[{"award-number":["860070"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Alzheimer\u2019s Disease (AD) and Parkinson\u2019s Disease (PD) represent two among the most frequent neurodegenerative diseases worldwide. A common hallmark of these pathologies is the misfolding and consequent aggregation of amyloid proteins into soluble oligomers and insoluble \u03b2-sheet-rich fibrils, which ultimately lead to neurotoxicity and cell death. After a hundred years of research on the subject, this is the only reliable histopathological feature in our hands. Since AD and PD are diagnosed only once neuronal death and the first symptoms have appeared, the early detection of these diseases is currently impossible. At present, there is no effective drug available, and patients are left with symptomatic and inconclusive therapies. Several reasons could be associated with the lack of effective therapeutic treatments. One of the most important factors is the lack of selective probes capable of detecting, as early as possible, the most toxic amyloid species involved in the onset of these pathologies. In this regard, chemical probes able to detect and distinguish among different amyloid aggregates are urgently needed. In this article, we will review and put into perspective results from ex vivo and in vivo studies performed on compounds specifically interacting with such early species. Following a general overview on the three different amyloid proteins leading to insoluble \u03b2-sheet-rich amyloid deposits (amyloid \u03b21\u201342 peptide, Tau, and \u03b1-synuclein), a list of the advantages and disadvantages of the approaches employed to date is discussed, with particular attention paid to the translation of fluorescence imaging into clinical applications. Furthermore, we also discuss how the progress achieved in detecting the amyloids of one neurodegenerative disease could be leveraged for research into another amyloidosis. As evidenced by a critical analysis of the state of the art, substantial work still needs to be conducted. Indeed, the early diagnosis of neurodegenerative diseases is a priority, and we believe that this review could be a useful tool for better investigating this field.<\/jats:p>","DOI":"10.3390\/molecules29030722","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T07:50:12Z","timestamp":1707205812000},"page":"722","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers"],"prefix":"10.3390","volume":"29","author":[{"given":"Nicol\u00f2","family":"Bisi","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CNRS, BioCIS, Bat. Henri Moissan, 17, Av. des Sciences, 91400 Orsay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5572-2121","authenticated-orcid":false,"given":"Luca","family":"Pinzi","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, Via Giuseppe Campi 103, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-0607","authenticated-orcid":false,"given":"Giulio","family":"Rastelli","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, Via Giuseppe Campi 103, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1435-5676","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Tonali","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, CNRS, BioCIS, Bat. Henri Moissan, 17, Av. des Sciences, 91400 Orsay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,4]]},"reference":[{"key":"ref_1","unstructured":"(2022, November 21). Key Figures. Available online: https:\/\/institutducerveau-icm.org\/en\/key-figures\/."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Erkkinen, M.G., Kim, M.-O., and Geschwind, M.D. (2018). Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol., 10.","DOI":"10.1101\/cshperspect.a033118"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"A-Synuclein in Filamentous Inclusions of Lewy Bodies from Parkinson\u2019s Disease and Dementia with Lewy Bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The Amyloid Hypothesis in Alzheimer Disease: New Insights from New Therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41401-019-0304-y","article-title":"Advances in the Development of Imaging Probes and Aggregation Inhibitors for Alpha-Synuclein","volume":"41","author":"Xu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00259-015-3228-x","article-title":"Diagnostic Accuracy of 18F Amyloid PET Tracers for the Diagnosis of Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"43","author":"Morris","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1474-4422(11)70123-5","article-title":"Clinical Amyloid Imaging in Alzheimer\u2019s Disease","volume":"10","author":"Herholz","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.20524","article-title":"Amyloid-\u03b2 Oligomers Are Inefficiently Measured by Enzyme-Linked Immunosorbent Assay","volume":"58","author":"Stenh","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1016\/j.bmc.2010.06.044","article-title":"Synthesis and Evaluation of Stilbene Derivatives as a Potential Imaging Agent of Amyloid Plaques","volume":"18","author":"Hong","year":"2010","journal-title":"Bioorganic Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3233\/JAD-2010-100609","article-title":"Interference from Heterophilic Antibodies in Amyloid-\u03b2 Oligomer ELISAs","volume":"21","author":"Sehlin","year":"2010","journal-title":"J. Alzheimer\u2019s Dis. JAD"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neurobiolaging.2016.02.034","article-title":"Geneva Task Force for the Roadmap of Alzheimer\u2019s Biomarkers Clinical Validity of Cerebrospinal Fluid A\u03b242, Tau, and Phospho-Tau as Biomarkers for Alzheimer\u2019s Disease in the Context of a Structured 5-Phase Development Framework","volume":"52","author":"Mattsson","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-Synuclein Strains in Parkinson\u2019s Disease and Multiple System Atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mcn.2018.12.001","article-title":"Biomarkers for Tau Pathology","volume":"97","author":"Maass","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2217\/17520363.2.4.363","article-title":"Tau as a Biomarker of Neurodegenerative Diseases","volume":"2","author":"Sergeant","year":"2008","journal-title":"Biomark. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF Markers for Incipient Alzheimer\u2019s Disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.0b013e3181dd4dd8","article-title":"CSF Biomarkers Predict a More Malignant Outcome in Alzheimer Disease","volume":"74","author":"Wallin","year":"2010","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal Fluid Levels Of\u03b2-Amyloid 1\u201342, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch. General. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1471-4159.2012.07911.x","article-title":"Development and Assessment of Sensitive Immuno-PCR Assays for the Quantification of Cerebrospinal Fluid Three- and Four-Repeat Tau Isoforms in Tauopathies","volume":"123","author":"Luk","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1021\/acs.jproteome.5b01001","article-title":"Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity","volume":"15","author":"Fenaille","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41582-020-0348-0","article-title":"An Update on Blood-Based Biomarkers for Non-Alzheimer Neurodegenerative Disorders","volume":"16","author":"Ashton","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41582-022-00665-2","article-title":"Blood Phospho-Tau in Alzheimer Disease: Analysis, Interpretation, and Clinical Utility","volume":"18","author":"Karikari","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13195-022-01011-w","article-title":"Diagnostic Value of Serum versus Plasma Phospho-Tau for Alzheimer\u2019s Disease","volume":"14","author":"Kac","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood Phosphorylated Tau 181 as a Biomarker for Alzheimer\u2019s Disease: A Diagnostic Performance and Prediction Modelling Study Using Data from Four Prospective Cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-Tau181 in Alzheimer\u2019s Disease: Relationship to Other Biomarkers, Differential Diagnosis, Neuropathology and Longitudinal Progression to Alzheimer\u2019s Dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma Phospho-Tau181 Increases with Alzheimer\u2019s Disease Clinical Severity and Is Associated with Tau-PET and Amyloid-PET","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma P-Tau231: A New Biomarker for Incipient Alzheimer\u2019s Disease Pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic Value of Plasma Phosphorylated Tau181 in Alzheimer\u2019s Disease and Frontotemporal Lobar Degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-Tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-021-00939-9","article-title":"Clinical and Analytical Comparison of Six Simoa Assays for Plasma P-Tau Isoforms P-Tau181, P-Tau217, and P-Tau231","volume":"13","author":"Bayoumy","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau Biomarkers in Alzheimer\u2019s Disease: Towards Implementation in Clinical Practice and Trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.urine.2023.06.001","article-title":"Urine; a New Promising Biological Fluid to Act as a Non-Invasive Biomarker for Different Human Diseases","volume":"5","author":"Balhara","year":"2023","journal-title":"URINE"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/14789450.2016.1190651","article-title":"Current State of the Art for Enhancing Urine Biomarker Discovery","volume":"13","author":"Harpole","year":"2016","journal-title":"Expert. Rev. Proteom."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/ene.15641","article-title":"Brain-Specific Biomarkers in Urine as a Non-Invasive Approach to Monitor Neuronal and Glial Damage","volume":"30","author":"Kohlhase","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2011-110731","article-title":"Salivary Tau Species Are Potential Biomarkers of Alzheimer\u2019s Disease","volume":"27","author":"Shi","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1014305","DOI":"10.3389\/fnagi.2022.1014305","article-title":"Saliva Tau and Phospho-Tau-181 Measured by Lumipulse in Patients with Alzheimer\u2019s Disease","volume":"14","author":"Marksteiner","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_36","first-page":"53","article-title":"Development and Validation of a Salivary Tau Biomarker in Alzheimer\u2019s Disease","volume":"11","author":"Pekeles","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2217\/bmm-2017-0433","article-title":"Update on Biomarkers for Amyloid Pathology in Alzheimer\u2019s Disease","volume":"12","author":"Ashton","year":"2018","journal-title":"Biomark. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ibneur.2023.03.004","article-title":"Salivary Levels of Disease-Related Biomarkers in the Early Stages of Parkinson\u2019s and Alzheimer\u2019s Disease: A Cross-Sectional Study","volume":"14","author":"Sabaei","year":"2023","journal-title":"IBRO Neurosci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lau, H.-C., Lee, I.-K., Ko, P.-W., Lee, H.-W., Huh, J.-S., Cho, W.-J., and Lim, J.-O. (2015). Non-Invasive Screening for Alzheimer\u2019s Disease by Sensing Salivary Sugar Using Drosophila Cells Expressing Gustatory Receptor (Gr5a) Immobilized on an Extended Gate Ion-Sensitive Field-Effect Transistor (EG-ISFET) Biosensor. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117810"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40120-019-00168-1","article-title":"Salivary Biomarkers for Alzheimer\u2019s Disease and Related Disorders","volume":"8","author":"Ashton","year":"2019","journal-title":"Neurol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1007\/s11306-015-0840-5","article-title":"The Human Saliva Metabolome","volume":"11","author":"Dame","year":"2015","journal-title":"Metabolomics"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kr\u00f3l-Grzyma\u0142a, A., Sienkiewicz-Sz\u0142apka, E., Fiedorowicz, E., Rozmus, D., Cie\u015bli\u0144ska, A., and Grzybowski, A. (2022). Tear Biomarkers in Alzheimer\u2019s and Parkinson\u2019s Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review). Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231710123"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"22675","DOI":"10.1038\/s41598-021-01993-x","article-title":"Association of Tear Fluid Amyloid and Tau Levels with Disease Severity and Neurodegeneration","volume":"11","author":"Gijs","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Gharbiya, M., Visioli, G., Trebbastoni, A., Albanese, G.M., Colardo, M., D\u2019Antonio, F., Segatto, M., and Lambiase, A. (2023). Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer\u2019s Disease Correlated with Choroidal Thickness. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032590"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00688261","article-title":"Olfactory Bulb Changes in Alzheimer\u2019s Disease","volume":"73","author":"Ohm","year":"1987","journal-title":"Acta Neuropathol."},{"key":"ref_46","first-page":"265","article-title":"Olfactory Tau Pathology in Alzheimer Disease and Mild Cognitive Impairment","volume":"25","author":"Attems","year":"2006","journal-title":"Clin. Neuropathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12078-015-9198-3","article-title":"Tau Protein Detection in Anosmic Alzheimer\u2019s Disease Patient\u2019s Nasal Secretions","volume":"8","author":"Passali","year":"2015","journal-title":"Chemosens. Percept."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/ADR-210298","article-title":"Nasal Extracts from Patients with Alzheimer\u2019s Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation","volume":"5","author":"Yanagisawa","year":"2021","journal-title":"J. Alzheimer\u2019s Dis. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1021\/acschemneuro.9b00199","article-title":"Fluorescence Chemicals To Detect Insoluble and Soluble Amyloid-\u03b2 Aggregates","volume":"10","author":"Lee","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Hua, J., Ding, D., and Tang, Y. (2022). Interrogating Amyloid Aggregation with Aggregation-Induced Emission Fluorescence Probes. Biomaterials, 286.","DOI":"10.1016\/j.biomaterials.2022.121605"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1039\/D3OB00509G","article-title":"Recent Developments in the Chemical Biology of Amyloid-\u03b2 Oligomer Targeting","volume":"21","author":"Wang","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1002\/anie.200461600","article-title":"Solid-Phase Synthesis of Styryl Dyes and Their Application as Amyloid Sensors","volume":"43","author":"Li","year":"2004","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/cbic.200700154","article-title":"Styryl-Based Compounds as Potential in Vivo Imaging Agents for Beta-Amyloid Plaques","volume":"8","author":"Li","year":"2007","journal-title":"Chembiochem"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/ml3003605","article-title":"A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer\u2019s and Prion Diseases","volume":"4","author":"Staderini","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1039\/C3CC45201H","article-title":"Direct \u03b2-Acylation of 2-Arylidene-1,3-Indandiones with Acyl Chlorides Catalyzed by Organophosphanes","volume":"50","author":"Lee","year":"2014","journal-title":"Chem. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt1085","article-title":"In Vivo Detection of Amyloid-Beta Deposits by near-Infrared Imaging Using an Oxazine-Derivative Probe","volume":"23","author":"Hintersteiner","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1002\/anie.200500845","article-title":"In Vivo Optical Imaging of Amyloid Aggregates in Brain: Design of Fluorescent Markers","volume":"44","author":"Nesterov","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1007\/s00259-007-0708-7","article-title":"Smart Optical Probes for Near-Infrared Fluorescence Imaging of Alzheimer\u2019s Disease Pathology","volume":"35","author":"Raymond","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"16397","DOI":"10.1021\/ja405239v","article-title":"Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer\u2019s Disease","volume":"135","author":"Zhang","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/cn200122j","article-title":"Bivalent Ligand Containing Curcumin and Cholesterol as Fluorescence Probe for A\u03b2 Plaques in Alzheimer\u2019s Disease","volume":"3","author":"Liu","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15257","DOI":"10.1021\/ja9047043","article-title":"Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-\u03b2 Deposits","volume":"131","author":"Ran","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/j.bmcl.2010.05.027","article-title":"Development of Dual Functional SPECT\/Fluorescent Probes for Imaging Cerebral Beta-Amyloid Plaques","volume":"20","author":"Ono","year":"2010","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1007\/s12272-015-0617-4","article-title":"Development of Fluorescent Probes That Bind and Stain Amyloid Plaques in Alzheimer\u2019s Disease","volume":"38","author":"Jung","year":"2015","journal-title":"Arch. Pharmacal Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1021\/acschemneuro.9b00093","article-title":"Fluorescent 1,4-Naphthoquinones To Visualize Diffuse and Dense-Core Amyloid Plaques in APP\/PS1 Transgenic Mouse Brains","volume":"10","author":"Jeon","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/cn3000058","article-title":"BODIPY-Based Molecular Probe for Imaging of Cerebral \u03b2-Amyloid Plaques","volume":"3","author":"Ono","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/anie.200702070","article-title":"The Chemistry of Fluorescent Bodipy Dyes: Versatility Unsurpassed","volume":"47","author":"Ulrich","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1039\/C1CS15132K","article-title":"Fluorescent Indicators Based on BODIPY","volume":"41","author":"Boens","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbrc.2009.12.091","article-title":"Triazole-Containing BODIPY Dyes as Novel Fluorescent Probes for Soluble Oligomers of Amyloid Abeta1\u201342 Peptide","volume":"391","author":"Smith","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/acs.bioconjchem.8b00623","article-title":"Fluorescent Imaging of \u03b2-Amyloid Using BODIPY Based Near-Infrared Off-On Fluorescent Probe","volume":"29","author":"Ren","year":"2018","journal-title":"Bioconjugate Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1021\/acs.jmedchem.5b00861","article-title":"Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-\u03b2 Plaques in Alzheimer\u2019s Disease","volume":"58","author":"Fu","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1021\/acs.analchem.5b04441","article-title":"Amyloid-\u03b2 Deposits Target Efficient Near-Infrared Fluorescent Probes: Synthesis, in Vitro Evaluation, and in Vivo Imaging","volume":"88","author":"Fu","year":"2016","journal-title":"Anal. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/ja4052922","article-title":"Smart Near-Infrared Fluorescence Probes with Donor\u2013Acceptor Structure for in Vivo Detection of \u03b2-Amyloid Deposits","volume":"136","author":"Cui","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1021\/jacs.5b03548","article-title":"Two-Photon Absorbing Dyes with Minimal Autofluorescence in Tissue Imaging: Application to in Vivo Imaging of Amyloid-\u03b2 Plaques with a Negligible Background Signal","volume":"137","author":"Kim","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"22728","DOI":"10.1038\/srep22728","article-title":"Soluble Amyloid Beta Oligomers Block the Learning-Induced Increase in Hippocampal Sharp Wave-Ripple Rate and Impair Spatial Memory Formation","volume":"6","author":"Nicole","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","article-title":"Soluble A\u03b2 Oligomer Production and Toxicity","volume":"120","author":"Larson","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.1073\/pnas.1505420112","article-title":"Near-Infrared Fluorescence Molecular Imaging of Amyloid Beta Species and Monitoring Therapy in Animal Models of Alzheimer\u2019s Disease","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"13503","DOI":"10.1021\/jacs.5b06190","article-title":"Chemical Fluorescent Probe for Detection of A\u03b2 Oligomers","volume":"137","author":"Teoh","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.bmcl.2013.01.065","article-title":"Aza-BODIPY: Improved Synthesis and Interaction with Soluble A\u03b21\u201342 Oligomers","volume":"23","author":"Jameson","year":"2013","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1039\/C9CC08894F","article-title":"Highly Specific Detection of A\u03b2 Oligomers in Early Alzheimer\u2019s Disease by a near-Infrared Fluorescent Probe with a \u201cV-Shaped\u201d Spatial Conformation","volume":"56","author":"Yang","year":"2020","journal-title":"Chem. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"131481","DOI":"10.1016\/j.snb.2022.131481","article-title":"Detection of A\u03b2 Oligomers in Early Alzheimer\u2019s Disease Diagnose by in Vivo NIR-II Fluorescence Imaging","volume":"358","author":"Li","year":"2022","journal-title":"Sens. Actuators B Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1039\/C7SC03974C","article-title":"Fluoro-Substituted Cyanine for Reliable in Vivo Labelling of Amyloid-\u03b2 Oligomers and Neuroprotection against Amyloid-\u03b2 Induced Toxicity","volume":"8","author":"Li","year":"2017","journal-title":"Chem. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A Protein Factor Essential for Microtubule Assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","article-title":"Cloning and Sequencing of the CDNA Encoding a Core Protein of the Paired Helical Filament of Alzheimer Disease: Identification as the Microtubule-Associated Protein Tau","volume":"85","author":"Goedert","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1096\/fj.07-096909","article-title":"Tau Isoform Expression and Regulation in Human Cortical Neurons","volume":"22","author":"Deshpande","year":"2008","journal-title":"FASEB J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of Tau Protein in Health and Disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","article-title":"Is Alzheimer\u2019s Disease a Systemic Disease?","volume":"1842","author":"Morris","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Tabeshmehr, P., and Eftekharpour, E. (2023). Tau; One Protein, So Many Diseases. Biology, 12.","DOI":"10.3390\/biology12020244"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","article-title":"Microtubule-Associated Protein Tau in Development, Degeneration and Protection of Neurons","volume":"85","author":"Wang","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"ref_89","first-page":"731526","article-title":"Structure and Pathology of Tau Protein in Alzheimer Disease","volume":"2012","author":"Kolarova","year":"2012","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"ref_90","first-page":"251426","article-title":"Protein Tau: Prime Cause of Synaptic and Neuronal Degeneration in Alzheimer\u2019s Disease","volume":"2012","author":"Theunis","year":"2012","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"23780","DOI":"10.1039\/C8RA03620A","article-title":"Current Progress, Challenges and Future Prospects of Diagnostic and Therapeutic Interventions in Alzheimer\u2019s Disease","volume":"8","author":"Rajasekhar","year":"2018","journal-title":"RSC Adv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"590896","DOI":"10.3389\/fnmol.2020.590896","article-title":"New Insights Into Drug Discovery Targeting Tau Protein","volume":"13","author":"Soeda","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Pinzi, L., Tinivella, A., and Rastelli, G. (2021). Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies. Molecules, 26.","DOI":"10.3390\/molecules26165039"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.drudis.2022.01.009","article-title":"Tau Protein Aggregation: Key Features to Improve Drug Discovery Screening","volume":"27","author":"Giovannini","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"134919","DOI":"10.1016\/j.neulet.2020.134919","article-title":"Targeting Tau: Clinical Trials and Novel Therapeutic Approaches","volume":"731","author":"VandeVrede","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.4103\/1673-5374.373670","article-title":"Therapies for Tau-Associated Neurodegenerative Disorders: Targeting Molecules, Synapses, and Cells","volume":"18","author":"Robbins","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fmre.2022.10.009","article-title":"Targeting Amyloid Proteins for Clinical Diagnosis of Neurodegenerative Diseases","volume":"3","author":"Zhang","year":"2023","journal-title":"Fundam. Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Pinzi, L., Bisi, N., Sorbi, C., Franchini, S., Tonali, N., and Rastelli, G. (2023). Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status. Molecules, 28.","DOI":"10.3390\/molecules28114544"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer\u2019s Disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zhang, H., Cao, Y., Ma, L., Wei, Y., and Li, H. (2021). Possible Mechanisms of Tau Spread and Toxicity in Alzheimer\u2019s Disease. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.707268"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","article-title":"Tauopathies: New Perspectives and Challenges","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Chang, H.-Y., Sang, T.-K., and Chiang, A.-S. (2018). Untangling the Tauopathy for Alzheimer\u2019s Disease and Parkinsonism. J. Biomed. Sci., 25.","DOI":"10.1186\/s12929-018-0457-x"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11910-019-0962-7","article-title":"Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography","volume":"19","author":"Wang","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau Imaging: Early Progress and Future Directions","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fnins.2017.00120","article-title":"The Changing Landscape of Neuroscience Research, 2006\u20132015: A Bibliometric Study","volume":"11","author":"Yeung","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fneur.2015.00038","article-title":"PET Imaging of Tau Pathology in Alzheimer\u2019s Disease and Tauopathies","volume":"6","author":"James","year":"2015","journal-title":"Front. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JAD-2011-0008","article-title":"The Merits of FDDNP-PET Imaging in Alzheimer\u2019s Disease","volume":"26","author":"Shin","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrneurol.2013.216","article-title":"Alzheimer Disease: [11C]PBB3--a New PET Ligand That Identifies Tau Pathology in the Brains of Patients with AD","volume":"9","author":"Wood","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1523\/JNEUROSCI.1738-05.2005","article-title":"Quinoline and Benzimidazole Derivatives: Candidate Probes for in Vivo Imaging of Tau Pathology in Alzheimer\u2019s Disease","volume":"25","author":"Okamura","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awr038","article-title":"18F-THK523: A Novel in Vivo Tau Imaging Ligand for Alzheimer\u2019s Disease","volume":"134","author":"Okamura","year":"2011","journal-title":"Brain"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00259-012-2261-2","article-title":"Comparison of the Binding Characteristics of [18F]THK-523 and Other Amyloid Imaging Tracers to Alzheimer\u2019s Disease Pathology","volume":"40","author":"Harada","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","article-title":"Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease","volume":"54","author":"Okamura","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00259-013-2681-7","article-title":"In Vivo Evaluation of a Novel Tau Imaging Tracer for Alzheimer\u2019s Disease","volume":"41","author":"Villemagne","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/brain\/awu064","article-title":"Non-Invasive Assessment of Alzheimer\u2019s Disease Neurofibrillary Pathology Using 18F-THK5105 PET","volume":"137","author":"Okamura","year":"2014","journal-title":"Brain"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s00259-015-3035-4","article-title":"[18F]THK-5117 PET for Assessing Neurofibrillary Pathology in Alzheimer\u2019s Disease","volume":"42","author":"Harada","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease","volume":"57","author":"Harada","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_118","unstructured":"Commissioner, O. (2023, November 25). Of the FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer\u2019s Disease, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-image-tau-pathology-patients-being-evaluated-alzheimers-disease."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2967\/jnumed.120.252411","article-title":"First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease","volume":"61","author":"Barthel","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00259-021-05673-w","article-title":"International Consensus on the Use of Tau PET Imaging Agent 18F-Flortaucipir in Alzheimer\u2019s Disease","volume":"49","author":"Tian","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","article-title":"Tau-Positron Emission Tomography Correlates with Neuropathology Findings","volume":"16","author":"Lowe","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[(18)F]T807, a Novel Tau Positron Emission Tomography Imaging Agent for Alzheimer\u2019s Disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating Novel Tau Positron Emission Tomography Tracer [F-18]-AV-1451 (T807) on Postmortem Brain Tissue","volume":"78","author":"Normandin","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron Emission Tomography Imaging With [18F]Flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.27271","article-title":"The Tau Positron-Emission Tomography Tracer AV-1451 Binds with Similar Affinities to Tau Fibrils and Monoamine Oxidases","volume":"33","author":"Vermeiren","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","article-title":"Overview of Tau PET Molecular Imaging","volume":"35","author":"Roytman","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fnagi.2017.00440","article-title":"[18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy","volume":"9","author":"Brendel","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1177\/0271678X16683695","article-title":"Positron Emission Tomography Imaging of Tau Pathology in Progressive Supranuclear Palsy","volume":"37","author":"Coakeley","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET Imaging in Neurodegenerative Tauopathies-Still a Challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00259-020-05118-w","article-title":"Clinical Validity of Increased Cortical Uptake of [18F]Flortaucipir on PET as a Biomarker for Alzheimer\u2019s Disease in the Context of a Structured 5-Phase Biomarker Development Framework","volume":"48","author":"Wolters","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2967\/jnumed.123.265593","article-title":"Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers","volume":"64","author":"Harada","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41380-022-01875-2","article-title":"Discriminative Binding of Tau PET Tracers PI2620, MK6240 and RO948 in Alzheimer\u2019s Disease, Corticobasal Degeneration and Progressive Supranuclear Palsy Brains","volume":"28","author":"Malarte","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2016.11.005","article-title":"Synergistic Interaction between Amyloid and Tau Predicts the Progression to Dementia","volume":"13","author":"Pascoal","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2967\/jnumed.119.236224","article-title":"Tau PET Imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study","volume":"61","author":"Mueller","year":"2020","journal-title":"J. Nucl. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","article-title":"Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders","volume":"77","author":"Leuzy","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Rowe, C.C., Dor\u00e9, V., Krishnadas, N., Burnham, S., Lamb, F., Mulligan, R., Bozinovski, S., Laws, S., Tyrell, R., and Huang, K. (2022). Tau Imaging with 18F-MK6240 across the Alzheimer\u2019s Disease Spectrum. medRxiv, medRxiv:2022.02.13.22270894.","DOI":"10.1101\/2022.02.13.22270894"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"789054","DOI":"10.3389\/fnagi.2021.789054","article-title":"18F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer\u2019s Disease","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1038\/s41467-023-38537-y","article-title":"Stacked Binding of a PET Ligand to Alzheimer\u2019s Tau Paired Helical Filaments","volume":"14","author":"Merz","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-022-32951-4","article-title":"Structure-Based Discovery of Small Molecules That Disaggregate Alzheimer\u2019s Disease Tissue Derived Tau Fibrils in Vitro","volume":"13","author":"Seidler","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2021.4654","article-title":"Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease","volume":"79","author":"Leuzy","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-2010-1262","article-title":"Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer\u2019s Disease","volume":"19","author":"Rojo","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Yeo, S.K., Shepelytskyi, Y., Grynko, V., and Albert, M.S. (2020). Molecular Imaging of Fluorinated Probes for Tau Protein and Amyloid-\u03b2 Detection. Molecules, 25.","DOI":"10.3390\/molecules25153413"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"791679","DOI":"10.3389\/fnagi.2021.791679","article-title":"Magnetic Resonance Imaging in Tauopathy Animal Models","volume":"13","author":"Ni","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3233\/JAD-160907","article-title":"Recent Progress in Alzheimer\u2019s Disease Research, Part 3: Diagnosis and Treatment","volume":"57","author":"Hane","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer Disease: Epidemiology, Diagnostic Criteria, Risk Factors and Biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The Clinical Use of Structural MRI in Alzheimer Disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nn1422","article-title":"19F and 1H MRI Detection of Amyloid \u03b2 Plaques In Vivo","volume":"8","author":"Higuchi","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2463\/mrms.9.95","article-title":"Amyloid Imaging Using High-Field Magnetic Resonance","volume":"9","author":"Amatsubo","year":"2010","journal-title":"Magn. Reson. Med. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jnr.24188","article-title":"Fluorine-19 Magnetic Resonance Imaging Probe for the Detection of Tau Pathology in Female RTg4510 Mice","volume":"96","author":"Yanagisawa","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e041080","DOI":"10.1002\/alz.041080","article-title":"A Novel MRI Contrast Agent for Identifying Hyperphosphorylative Neurons as a Marker of Future Tau Pathology","volume":"16","author":"Badachhape","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Yamanakkanavar, N., Choi, J.Y., and Lee, B. (2020). MRI Segmentation and Classification of Human Brain Using Deep Learning for Diagnosis of Alzheimer\u2019s Disease: A Survey. Sensors, 20.","DOI":"10.3390\/s20113243"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3233\/JAD-215497","article-title":"Predicting Brain Amyloid-\u03b2 PET Phenotypes with Graph Convolutional Networks Based on Functional MRI and Multi-Level Functional Connectivity","volume":"86","author":"Li","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13195-018-0428-1","article-title":"MRI Predictors of Amyloid Pathology: Results from the EMIF-AD Multimodal Biomarker Discovery Study","volume":"10","author":"Redolfi","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3233\/JAD-201092","article-title":"Machine Learning for the Prediction of Amyloid Positivity in Amnestic Mild Cognitive Impairment","volume":"80","author":"Kang","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e222441","DOI":"10.1148\/radiol.222441","article-title":"MRI-Based Deep Learning Assessment of Amyloid, Tau, and Neurodegeneration Biomarker Status across the Alzheimer Disease Spectrum","volume":"309","author":"Lew","year":"2023","journal-title":"Radiology"},{"key":"ref_156","first-page":"35","article-title":"Purification of Recombinant Tau Protein and Preparation of Alzheimer-Paired Helical Filaments in Vitro","volume":"299","author":"Barghorn","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"ref_157","first-page":"e51537","article-title":"In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein","volume":"95","author":"Sui","year":"2015","journal-title":"J. Vis. Exp."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/acssensors.1c00338","article-title":"\u201cTurn-On\u201d Quinoline-Based Fluorescent Probe for Selective Imaging of Tau Aggregates in Alzheimer\u2019s Disease: Rational Design, Synthesis, and Molecular Docking","volume":"6","author":"Elbatrawy","year":"2021","journal-title":"ACS Sens."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"117369","DOI":"10.1016\/j.trac.2023.117369","article-title":"Application of Biomarker-Derived Fluorescent Probes for the Detection of Alzheimer\u2019s Disease","volume":"169","author":"Ding","year":"2023","journal-title":"TrAC Trends Anal. Chem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1039\/C7CS00706J","article-title":"Shedding Light on Tau Protein Aggregation: The Progress in Developing Highly Selective Fluorophores","volume":"47","author":"Verwilst","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"13393","DOI":"10.1021\/jacs.7b05878","article-title":"Rational Design of in Vivo Tau Tangle-Selective Near-Infrared Fluorophores: Expanding the BODIPY Universe","volume":"139","author":"Verwilst","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1039\/C9SC05620C","article-title":"A Fluorescent Molecular Imaging Probe with Selectivity for Soluble Tau Aggregated Protein","volume":"11","author":"Zhao","year":"2020","journal-title":"Chem. Sci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1021\/cb900112v","article-title":"Novel Pentameric Thiophene Derivatives for in Vitro and in Vivo Optical Imaging of a Plethora of Protein Aggregates in Cerebral Amyloidoses","volume":"4","author":"Sigurdson","year":"2009","journal-title":"ACS Chem. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/bkcs.12361","article-title":"Thiophene-\u03c0-Cyanoacetamides Show Intense and Tau-Selective Turn-on Fluorescence in the Near-Infrared Region","volume":"42","author":"Oh","year":"2021","journal-title":"Bull. Korean Chem. Soc."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1038\/s41598-022-09016-z","article-title":"Rational Design and Synthesis of a Novel BODIPY-Based Probe for Selective Imaging of Tau Tangles in Human IPSC-Derived Cortical Neurons","volume":"12","author":"Soloperto","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting Alpha-Synuclein as a Therapy for Parkinson\u2019s Disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1002\/anie.201801071","article-title":"Inhibition of \u03b1-Synuclein Amyloid Fibril Elongation by Blocking Fibril Ends","volume":"57","author":"Shvadchak","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","article-title":"Retinal \u03b1-Synuclein Deposits in Parkinson\u2019s Disease Patients and Animal Models","volume":"137","author":"Veys","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.bbagen.2015.05.021","article-title":"Anle138b and Related Compounds Are Aggregation Specific Fluorescence Markers and Reveal High Affinity Binding to \u03b1-Synuclein Aggregates","volume":"1850","author":"Deeg","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.15252\/emmm.201707825","article-title":"The Diphenylpyrazole Compound Anle138b Blocks A\u03b2 Channels and Rescues Disease Phenotypes in a Mouse Model for Amyloid Pathology","volume":"10","author":"Urbanke","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00401-015-1483-3","article-title":"Reducing Tau Aggregates with Anle138b Delays Disease Progression in a Mouse Model of Tauopathies","volume":"130","author":"Wagner","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/acschemneuro.6b00450","article-title":"Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of \u03b2-Amyloid and \u03b1-Synuclein Aggregates","volume":"8","author":"Watanabe","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of Full-Length \u03b1-Synuclein Reveals Fibril Polymorphs with a Common Structural Kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-Synuclein Oligomers and Fibrils: A Spectrum of Species, a Spectrum of Toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acschemneuro.1c00877","article-title":"Current Progress in the Development of Probes for Targeting \u03b1-Synuclein Aggregates","volume":"13","author":"Zeng","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Bagchi, D.P., Yu, L., Perlmutter, J.S., Xu, J., Mach, R.H., Tu, Z., and Kotzbauer, P.T. (2013). Binding of the Radioligand SIL23 to \u03b1-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055031"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Korat, \u0160., Bidesi, N.S.R., Bonanno, F., Di Nanni, A., Ho\u00e0ng, A.N.N., Herfert, K., Maurer, A., Battisti, U.M., Bowden, G.D., and Thonon, D. (2021). Alpha-Synuclein PET Tracer Development\u2014An Overview about Current Efforts. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090847"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1021\/acs.jmedchem.5b00571","article-title":"Design, Synthesis, and Characterization of 3-(Benzylidene)Indolin-2-One Derivatives as Ligands for \u03b1-Synuclein Fibrils","volume":"58","author":"Chu","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"44305","DOI":"10.1039\/C6RA02710E","article-title":"Structure\u2013Activity Relationships of Radioiodinated Diphenyl Derivatives with Different Conjugated Double Bonds as Ligands for \u03b1-Synuclein Aggregates","volume":"6","author":"Ono","year":"2016","journal-title":"RSC Adv."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1021\/acs.molpharmaceut.8b00229","article-title":"In Silico, in Vitro, and in Vivo Evaluation of New Candidates for \u03b1-Synuclein PET Imaging","volume":"15","author":"Verdurand","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/cmdc.201900689","article-title":"11C Radiolabeling of Anle253b: A Putative PET Tracer for Parkinson\u2019s Disease That Binds to A-Synuclein Fibrils in\u2005Vitro and Crosses the Blood-Brain Barrier","volume":"15","author":"Maurer","year":"2020","journal-title":"ChemMedChem"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00259-020-05133-x","article-title":"[11C]MODAG-001-towards a PET Tracer Targeting \u03b1-Synuclein Aggregates","volume":"48","author":"Kuebler","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1021\/acschemneuro.0c00523","article-title":"Identification and Evaluation of Bisquinoline Scaffold as a New Candidate for \u03b1-Synuclein-PET Imaging","volume":"11","author":"Kaide","year":"2020","journal-title":"ACS Chem. Neurosci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/3\/722\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:54:48Z","timestamp":1760104488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/3\/722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,4]]},"references-count":183,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["molecules29030722"],"URL":"https:\/\/doi.org\/10.3390\/molecules29030722","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,4]]}}}